comprehensive -WSS

comprehensive

author：focus 2025-09-10 16:44:57 - browse：1451

WASHINGTON — Grail is aggressively lobbying to get Medicare to pay for its cancer-screening test Galleri — but experts tell STAT that the company has a far more complicated path to that end than the makers of most medicines or medical devices.

Grail’s controversial blood test Galleri screens for multiple cancers. The Food and Drug Administration has not yet approved it, so Medicare hasn’t had to make a decision on whether to cover it or not. Right now, most people pay for it out of pocket. It runs about $950.

In general, Medicare covers FDA-approved medicines and medical devices that help diagnose or treat disease or injury. But there’s a catch for Grail: Medicare doesn’t cover tests that simply screen healthy people, as Galleri does.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Children’s Hospital revives plan for pedestrian bridge

WSS

The most pressing bird flu mysteries scientists want answered

The most pressing bird flu mysteries scientists want answered

Pfizer is about to make a big push in cancer. Will investors listen?

The most pressing bird flu mysteries scientists want answered

ASCO Daily Recap: CAR

STAT wants to know your pick for a great summer read or listen

hotspot

comprehensive

focus

Activists slam private health insurers over coverage restrictions

CMS got Medicare Advantage quality rating wrong, judge rules

Apple is now the first public company to be valued at $3 trillion

NEJM study measures Covid brain fog, impact on IQ

Continuity nursing helped my family in our darkest PICU moments

Elisabeth Bik tackles the widespread issue of research misconduct

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Congress needs to close a vaccine

Walensky prepares to leave CDC — and Congress — behind

Structure Therapeutics oral GLP

focus

Senators tussle over abortion against the backdrop of a presidential campaign

NEJM study measures Covid brain fog, impact on IQ

UnitedHealth CEO's Medicaid comments send insurer stocks diving

Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

STAT Madness 2024: Meet the contenders

NEJM study measures Covid brain fog, impact on IQ

knowledge

leisure time

Wikipedia

focus